Concepedia

Publication | Closed Access

Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023

DOI

21

Citations

24

References

2012

Year

Bojana Milojkovic Kerklaan, Véronique Dièras, Christophe Le Tourneau, Marja Mergui‐Roelvink, Alwin D. R. Huitema, Hilde Rosing, J. Beijnen, Sandrine Marréaud, Anne-Sophie Govaerts, Martine Piccart,
Cancer Chemotherapy and Pharmacology

References

YearCitations

Page 1